Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07081503
PHASE1

Phase 1 Study of ADX-626 in Healthy Participants

Sponsor: ADARx Pharmaceuticals, Inc.

View on ClinicalTrials.gov

Summary

This first-in-human study will evaluate the safety and tolerability of ADX-626 in healthy participants. The study will also look at how ADX-626 interacts with the human body (the pharmacokinetics and pharmacodynamics of ADX-626).

Official title: A Phase 1, Randomized, Blinded, Placebo-Controlled Study to Assess ADX-626 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

44

Start Date

2025-08-12

Completion Date

2027-01-22

Last Updated

2026-03-02

Healthy Volunteers

Yes

Interventions

DRUG

ADX-626

siRNA duplex oligonucleotide

DRUG

Placebo

Saline

Locations (1)

Richmond Pharmacology

London, United Kingdom